---
figid: PMC4148087__oncotarget-05-4603-g004
figtitle: 'Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer:
  possibilities for therapeutic intervention'
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC4148087
filename: oncotarget-05-4603-g004.jpg
figlink: /pmc/articles/PMC4148087/figure/F4/
number: F4
caption: The aromatase inhibitor (AI) letrozole prevents the conversion of testosterone
  (TEST) into estrogen (ER) and hence there is no ERalpha mediated gene transcription.
  Letrozole alters the expression of the PI3K/PTEN/Akt/mTORC1 pathway. PI3K inhibitors
  will restore ERalpha mediated gene expression in Letrozole resistant cells and the
  cells revert to hormonal sensitivity. Likewise PI3K inhibitors will restore the
  sensitivity of 4HT-resistant cells to 4HT. Breast cells with mutations at PIK3CA
  may develop resistance to 4HT and PI3K inhibitors may restore sensitivity to 4HT.
papertitle: 'Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer:
  possibilities for therapeutic intervention.'
reftext: Nicole M. Davis, et al. Oncotarget. 2014 Jul;5(13):4603-4650.
year: '2014'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9413315
figid_alias: PMC4148087__F4
figtype: Figure
redirect_from: /figures/PMC4148087__F4
ndex: 5e9e57dc-df04-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4148087__oncotarget-05-4603-g004.html
  '@type': Dataset
  description: The aromatase inhibitor (AI) letrozole prevents the conversion of testosterone
    (TEST) into estrogen (ER) and hence there is no ERalpha mediated gene transcription.
    Letrozole alters the expression of the PI3K/PTEN/Akt/mTORC1 pathway. PI3K inhibitors
    will restore ERalpha mediated gene expression in Letrozole resistant cells and
    the cells revert to hormonal sensitivity. Likewise PI3K inhibitors will restore
    the sensitivity of 4HT-resistant cells to 4HT. Breast cells with mutations at
    PIK3CA may develop resistance to 4HT and PI3K inhibitors may restore sensitivity
    to 4HT.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Shc
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Pten
  - era
  - Akt
  - Tsc
  - Tsc1
  - Crtc
  - tRNA:Lys-TTT-1-1
  - tRNA:Lys-TTT-2-4
  - tRNA:Lys-TTT-2-1
  - tRNA:Lys-TTT-2-2
  - tRNA:Lys-TTT-2-5
  - tRNA:Lys-TTT-2-3
  - de
  - se
  - IGF1
  - IGF1R
  - SHC1
  - SHC2
  - SHC3
  - SHC4
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - CPB1
  - PTEN
  - ESR1
  - ERAL1
  - AKT1
  - AKT2
  - AKT3
  - SLC12A3
  - TSC1
  - TESC
  - TSC2
  - MTOR
  - RPTOR
  - APP
  - AAAS
  - AAA1
  - Cancer
---
